Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06078878

Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter

Led by Gentuity, LLC · Updated on 2025-03-30

30

Participants Needed

1

Research Sites

198 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a prospective, single arm, unblinded, and open-label study. The study is designed to evaluate the use of the Gentuity Neurovascular Imaging System in patients undergoing elective neurointerventional diagnostic procedures.

CONDITIONS

Official Title

Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients electively scheduled for a follow-up cerebral angiogram or diagnostic angiogram and may be candidates for neuroendovascular procedures
  • Patients with a Modified Rankin Score (mRS) of 3 or less
  • Patients 18 years of age or older
  • Patients willing and able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Patients with serious medical conditions such as bacteremia, sepsis, acute renal failure at the time of procedure, or major coagulation abnormalities increasing risk
  • Pregnant patients
  • Known hypersensitivity to contrast media
  • Patients undergoing urgent or emergent neurointerventional procedures
  • Patients with a Modified Rankin Score (mRS) of 4 or more
  • Patients with unresolved spontaneous subarachnoid hemorrhage or intracranial hemorrhage
  • Participation in another clinical trial of investigational drug or device
  • Patients with an existing Flow Re-Direction Endoluminal Device (FRED4) System

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clínica La Sagrada Familia

Buenos Aires, Argentina, C1428ARJ

Actively Recruiting

Loading map...

Research Team

S

Sharon Timberlake, MSHS

CONTACT

A

Arjun Bhat, MD, MBA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here